Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

Peak Study - A Study of Pegasys (Peginterferon Alfa-2a (40KD)) in Combination With Copegus (Ribavirin) in Interferon-Naive Patients With Chronic Hepatitis C (CHC).

ClinicalTrials.gov ID: NCT00087607

Public ClinicalTrials.gov record NCT00087607. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 7:46 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Prospective, Randomized, Open-label Study Evaluating the Viral Kinetics and Pharmacokinetics of Pegasys® Plus Copegus® and PEG-Intron® Plus Rebetol® in Interferon-naïve Patients With Chronic Hepatitis C.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will examine the viral kinetics and pharmacokinetics of Pegasys plus ribavirin and PEG-Intron plus ribavirin in interferon-naive patients with CHC. The anticipated time on study treatment is 3-12 months, and the target sample size is 100-500 individuals.

Study identification

NCT ID
NCT00087607
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Hoffmann-La Roche
Industry
Enrollment
385 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 2003
Primary completion
Feb 28, 2006
Completion
Mar 31, 2006
Last update posted
Jun 30, 2016

2004 – 2006

United States locations

U.S. sites
41
U.S. states
22
U.S. cities
39
Facility City State ZIP Site status
Not listed Birmingham Alabama 35295-0005
Not listed Little Rock Arkansas 72205
Not listed Sacramento California 95817
Not listed San Diego California 92103
Not listed San Diego California 92123
Not listed San Francisco California 94143
Not listed San Mateo California 94403
Not listed San Rafael California 94901
Not listed Farmington Connecticut 06030
Not listed Hartford Connecticut 06015
Not listed Bradenton Florida 34209
Not listed Miami Florida 33125
Not listed Wellington Florida 33414
Not listed Kansas City Kansas 66160
Not listed New Orleans Louisiana 70115
Not listed Baltimore Maryland 21205
Not listed Boston Massachusetts 02215
Not listed Burlington Massachusetts 01805
Not listed Detroit Michigan 48201
Not listed Kansas City Missouri 64131
Not listed St Louis Missouri 63104
Not listed Omaha Nebraska 68198
Not listed Las Vegas Nevada 89128
Not listed East Orange New Jersey 07018
Not listed Egg Harbour Township New Jersey 08234
Not listed Vineland New Jersey 08360
Not listed New York New York 10016
Not listed New York New York 10021
Not listed Poughkeepsie New York 12601
Not listed The Bronx New York 10467
Not listed Fayetteville North Carolina 28304
Not listed Statesville North Carolina 28677
Not listed Portland Oregon 97239
Not listed Columbia South Carolina 29204
Not listed Austin Texas 78758
Not listed Dallas Texas 75203
Not listed Fairfax Virginia 22031
Not listed Norfolk Virginia 23502
Not listed Roanoke Virginia 24016
Not listed Tacoma Washington 98405
Not listed Racine Wisconsin 53405

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00087607, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 30, 2016 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00087607 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →